Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial

Journal of the American Academy of Dermatology

Volumn 54, Issue 2, 2006, Pages 242-250

  Thiboutot, Diane ^a   Pariser, David M ^b   Egan, Nancy ^c   Flores, Javier ^d   Herndon Jr , James H ^e   Kanof, Norman B ^f   Kempers, Steven E ^g   Maddin, Stuart ^h   Poulin, Yves P ⁱ   Wilson, David C ^j   Hwa, Joyce ^k   Liu, Yin ^k   Graeber, Michael ^k,l  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c International Research Services Inc   (United States)

^d International Dermatology Research   (United States)

^e Thomas J Stephens and Associates Inc   (United States)

^f International Research Services   (United States)

^g Minnesota Clinical Study Center   (United States)

^h Derm Trials Inc   (Canada)

ⁱ Centre Dermatologique du Quebec Metropolitan   (Canada)

^j Education and Research Foundation   (United States)

^k Galderma Research and Development   (United States)

^l Galderma Research and Development   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE;

ACNE VULGARIS; ADOLESCENT; ADULT; APPLICATION SITE BURNING; APPLICATION SITE DRYNESS; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; APPLICATION SITE REACTION; APPLICATION SITE SCABBING; ARTICLE; BURN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; FEMALE; GEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GELS; HUMANS; MALE; NAPHTHALENES; TREATMENT OUTCOME;

EID: 31344440015     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.10.879     Document Type: Article

References (25)

1. Prevalence, morbidity, and cost of dermatologic diseases J Invest Dermatol 73 1979 395 513
2. W.J. Cunliffe, and D.J. Gould Prevalence of facial acne vulgaris in late adolescence and in adults Br Med J 1 1979 1109 1110
3. R.P. Usatine, M.A. Quan, and R. Strick Acne vulgaris: a treatment update Hosp Pract (Off Ed) 33 1998 111 127
4. J.J. Leyden New understandings of the pathogenesis of acne J Am Acad Dermatol 32 Suppl 1995 S15 S25
5. D.A. Baur, and R.C.D. Butler Current concepts in the pathogenesis and treatment of acne J Oral Maxillofac Surg 56 1998 651 655
6. H. Gollnick, W. Cunliffe, D. Berson, B. Dreno, A. Finlay, and J.J. Leyden Management of acne: a report from a global alliance to improve outcomes in acne J Am Acad Dermatol 49 Suppl 2003 S1 S37
7. H. Gollnick, and M. Schramm Topical drug treatment in acne Dermatology 196 1998 119 125
8. R.N. Brogden, and K.L. Goa Adapalene: a review of its pharmacological properties and clinical potential in the management of mild to moderate acne Drugs 53 1997 511 519
9. S. Michel, A. Jomard, and M. Demarchez Pharacology of adapalene Br J Dermatol 139 Suppl 1998 3 7
10. B. Vega, A. Jomard, and S. Michel Regulation of human monocyte toll-like receptor 2 (TLR2) expression by adapalene [abstract] J Eur Acad Dermatol Venereol 16 Suppl 2002 123 124
11. W.J. Cunliffe, R. Caputo, B. Dreno, L. Förström, M. Heenen, and C.E. Orfanos Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and US multicenter trials J Am Acad Dermatol 36 Suppl 1997 S126 S134
12. A. Shalita, J.S. Weiss, D.K. Chalker, C.N. Ellis, A. Greenspan, and I.H. Katz A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial J Am Acad Dermatol 34 1996 482 485
13. E. Grosshans, R. Marks, J.M. Mascaro, H. Torras, J. Meynadier, and M. Alirezai Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life Br J Dermatol 139 1998 26 33
14. D. Thiboutot, M.H. Gold, M.T. Jarratt, S. Kang, D.L. Kaplan, and L. Millikan Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris Cutis 68 2001 10 19
15. W.J. Cunliffe, M. Poncet, C. Loesche, and M. Verschoore A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials Br J Dermatol 139 1998 48 56
16. J.E. Wolf Jr., D. Kaplan, S.J. Kraus, K.H. Loven, T. Rist, and L.J. Swinyer Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study J Am Acad Dermatol 49 Suppl 2003 S211 S217
17. W.J. Cunliffe, J. Meynadier, M. Alirezai, S.A. George, I. Coutts, and D.I. Roseeuw Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle J Am Acad Dermatol 49 Suppl 2003 S218 S226
18. Dosik JS, Homer K, Arsonnaud S. Cumulative irritation potential of adapalene cream and gel, 0.1% compared to tazarotene cream, 0.05% and 0.1%. Cutis 2005;75:289-93.
19. A. Greenspan, C. Loesche, N. Vendetti, K. Georgeian, R. Gilbert, and M. Poncet Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations Cutis 72 2003 76 81
20. B. Brand, R. Gilbert, M.D. Baker, M. Poncet, A. Greenspan, and K. Georgeian Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents J Am Acad Dermatol 49 Suppl 2003 S227 S232
21. F.E. Dunlap, O.H. Mills, M.R. Tuley, M.D. Baker, and R.T. Plott Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference Br J Dermatol 139 1998 17 22
22. D. Caron, V. Sorba, N. Kerrouche, N. Kerrouche, and A. Clucas Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients J Am Acad Dermatol 36 Suppl 1997 S110 S112
23. N. Egan, M.C. Loesche, and M.M. Baker Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris Cutis 68 Suppl 2001 20 24
24. D.M. Pariser, D.M. Thiboutot, S.D. Clark, T.M. Jones, Y. Liu, M. Graeber, and Adapalene Study Group The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle Cutis 76 2005 145 151
25. K.-Y. Liang, and S.L. Zeger Longitudinal data analysis using generalized linear models Biometrika 73 1986 13 22